Experts advocate cautious investment in multi-asset schemes like ICICI Pru Multi Asset and Kotak Multi Asset Allocator, especially in uncertain markets with rising gold prices and unexpected shifts, for diversified long-term gains.
Dr. Reddy’s Laboratories Q1 Results: PAT rises 2% YoY to Rs 1,418 crore, revenue jumps 11%
Dr Reddy’s Laboratories Q1 Results: Pharma major Dr. Reddy’s Laboratories reported a marginal 2% year-on-year (YoY) growth in its consolidated net profit at Rs 1,418